Doxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia
- 1 May 2012
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 159 (3) , 362-367
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 EB000188)
- Triangle MRSEC through a DMR MRSEC grant
- NIH Biotechnology Predoctoral Fellowship (T32 GM 8555)
- NSF MRSEC
This publication has 34 references indexed in Scilit:
- Quantitative Model of the Phase Behavior of Recombinant pH-Responsive Elastin-Like PolypeptidesBiomacromolecules, 2010
- Injectable intratumoral depot of thermally responsive polypeptide–radionuclide conjugates delays tumor progression in a mouse modelJournal of Controlled Release, 2010
- Recursive Directional Ligation by Plasmid Reconstruction Allows Rapid and Seamless Cloning of Oligomeric GenesBiomacromolecules, 2010
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injectionNature Materials, 2009
- Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency AnalysisBiotechnology Progress, 2008
- Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinibCancer Science, 2008
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences, 2008
- Impact of Single-chain Fv Antibody Fragment Affinity on Nanoparticle Targeting of Epidermal Growth Factor Receptor-expressing Tumor CellsJournal of Molecular Biology, 2007
- A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistanceInvestigational New Drugs, 2007
- Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude miceJournal of Controlled Release, 2006